Alkani, Ampaari .

HRN: 25-43-89  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2024
AMPICILLIN 500MG (VIAL)
07/04/2024
07/10/2024
IV
300mg
Q6hours
PCAP-C
Waiting Final Action 
10/30/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/30/2024
11/06/2024
IV
400mg
Q6h
BFC
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: